Characterization by means of Delaunay triangulation and Voronoi paving of the influence of anti-hormone and/or anti-growth factor antibodies on the in vitro cell growth of human colorectal neoplastic cell lines

International Journal of Oncology

Volumn 8, Issue 3, 1996, Pages 483-492

  Kruczynski, Anna ^a   Yeaton, Paul ^b   Darro, Francis ^c   Camby, Isabelle ^c   DePrez, Carine ^d   Martinez, Jean ^e   Pasteels, Jean Lambert ^c   Kiss, Robert ^c,f  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^e CNRS   (France)

^f FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Cell kinetics; Colorectal cancer; Digital cell image analysis; Hormone sensitivity; Human; In vitro; Proliferation; Voronoi paving

Indexed keywords

EPIDERMAL GROWTH FACTOR ANTIBODY; ESTRADIOL ANTIBODY; GASTRIN ANTIBODY; GONADORELIN ANTIBODY; TRANSFORMING GROWTH FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; MATHEMATICAL MODEL; PRIORITY JOURNAL;

EID: 0029882462     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.8.3.483     Document Type: Article

References (42)

1. Watson S, Durrant L, Elston P and Morris D: Inhibitory effects of the gastrin receptor antagonist (L-365,260) on gastrointestinal tumor cells. Cancer 68: 1255-1260, 1991.
2. Culouscou JM and Shoyab M: Purification of a colon cancer cell growth inhibitor and its identification as an insulin-like growth factor binding protein. Cancer Res 51: 2813-2819, 1991.
3. Brown J and Gallagher ND: A specific gastrin receptor site in the rat stomach. Biochem Biophys Acta 538: 42-49, 1978.
4. Soll AH, Amirian DA, Thomas LP, Reedy JJ and Elashoff JD: Gastrin receptors on isolated canine parietal cells. J Clin Invest 73: 1434-1447, 1934.
5. Takeuchi K, Speir GR and Johnson LR: Mucosal gastrin receptors: I. Assay standardization and fulfillment of receptor criteria. Am J Physiol 237: 284-294, 1979.
6. Frucht H, Gazdar AF, Park JA, Oie H and Jensen RT: Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res 52: 1114-1122, 1992.
7. Ishizuka J, Martinez J, Townsend CM Jr and Thompson JC: The effect of gastrin on growth of human stomach cancer cells. Ann Surg 215: 528-535, 1992.
8. Upp JR Jr, Singh P, Townsend CM Jr and Thompson JC: Clinical significance of gastrin receptors in human colon cancers. Cancer Res 49: 488-492, 1989.
9. Weinstock J and Baldwin GS: Binding of gastrin-17 to human gastric carcinoma cell lines. Cancer Res 48: 932-937, 1988.
10. Hoosein NM, Brattain DE, McKnight MK, Levine AE and Brattain MG: Characterization of the inhibitory effects of transforming growth factor-β on a human colon carcinoma cell line. Cancer Res 47: 2950-2954, 1987.
11. Kiss R, Salmon I, Pauwels O, Gras S, Danguy A, Etievant C, Pasteels JL and Martinez J: Influence of gastrin, estradiol and gonadoliberin on HCT-15 and LoVo in vitro culture human colorectal neoplastic cell proliferation and differentiation. Eur J Cancer 27: 1268-1274, 1991.
12. Kusyk CL, McNiel NO and Johnson LR: Stimulation of growth of a colon cancer cell line by gastrin. Am J Physiol 251: 597-601, 1986.
13. Smith JP and Solomon TE: Effects of gastrin, proglumide and somatostalin on growth of human colon cancer. Gastroenterology 95: 1541-1548, 1988.
14. Hoosein NM, Kiener PA, Curry RC and Brattain MG: Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin cholecystokinin-like peptide. Exp Cell Res 186: 15-21, 1990.
15. Watson SA, Durrant LG, Wencyk PM, Watson AL and Morris DL: Intracellular gastrin in human gastrointestinal tumor cells. J Natl Cancer Inst 83: 866-871, 1991.
16. Harrison JD, Watson S and Morris DL: The effect of sex hormones and tamoxifen on the growth of human gastric and colorectal cancer cell lines. Cancer 63: 2148-2151, 1989.
17. Meggouh F, Lointier P, Pezet D and Saez S: Status of sex steroid hormone receptors in large bowel cancer. Cancer 67: 1964-1970, 1991.
18. Koenders PG, Peters WHM, Wobbes Th, Beex LVAM, Nagengast FM and Benraad ThJ: Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue. Br J Cancer 65: 189-192, 1992.
19. Yasui W, Sumiyoshi H, Hata J, Kameda T, Ochiai A, Ito H and Tahara E: Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. Cancer Res 48: 137-141, 1988.
20. Coffey RJ, Goustin AS, Soderquist AM, Shipley GD, Wolfshohl J, Carpenter G and Moses HL: Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model. Cancer Res 47: 4590-4594, 1987.
21. Tanaka S, Imanishi KI, Yoshihara M, Haruma K, Sumii K, Kajiyama G and Akamatsu S: Immunoreactive transforming growth factor α is commonly present in colorectal neoplasia. Am J Pathol 139: 123-129, 1991.
22. Suardet L, Gaide AC, Calmes JM, Sordat B, Givel JC, Eliason JF, et al: Responsiveness of three newly established human colorectal cancer cell lines to transforming growth factors β-1 and β-2. Cancer Res 52: 3705-3712, 1992.
23. Mosman T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol Methods 65: 55-63, 1983.
24. Bhat NR, Hauser KF and Kindy MS: Cell proliferation and protooncogene induction in oligodendroglial progenitors. J Neurosci Res 32: 340-349, 1992.
25. Hamburger AW and Salmon SE: Primary bioassay of human tumor stem cells. Science 197: 461-463, 1977.
26. Kiss R, Salmon I, Camby I, Gras S and Pasteels JL: Characterization of factors in routine laboratory protocols which significantly influence the Feulgen reaction. J Histochem Cytochem 41: 935-945, 1993.
27. Darro F, Kruczynski A, Etievant C, Martinez J, Pasteels JL and Kiss R: Characterization of the differentiation of human colorectal cancer cell lines by means of Voronoi diagrams. Cytometry 14: 783-792, 1993.
28. Kiss R, Camby I, Salmon I, Van Ham PH, Brotchi J and Pastccls JL: Relationship between DNA ploidy level and tumor sociology behavior in 12 nervous cell lines. Cytometry 20: 118-126, 1995.
29. Dexter DL, Barbosa JA and Calabresi PN: Dimethyl formamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer Res 39: 1020-1025, 1979.
30. Drewinko B, Romsdahl MM, Yang LY, Ahearn MJ and Trujillo JM: Establishement of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Res 36: 467-475, 1976.
31. Darro F, Kruczynski A, Etievant C, Martinez J and Kiss R: Monitoring of morphonuclear characteristics of hormone-sensitive and -insensitive HCT-15 and LoVo human colorectal cells by means of digital cell image analysis. Anticancer Res 13: 515-522, 1993.
32. Alexander IE, Shine J and Sutherland RL: Prognostic regulation of estrogen receptor messenger RNA in human breast cancer cells. Mol Endocrinol 4: 821-828, 1990.
33. Rubin NH, Singh P, Alinder G, Greeley GH Jr, Rayford PL, Rietveld WJ and Thompson JC: Circadian rhythms in gastrin receptors in rat fundic stomach. Dig Dis Sci 33: 931-937, 1988.
34. Saceda M, Lippman ME, Lindsey RK, Puente M and Martin MB: Role of an estrogen receptor-dependent mechanism in the regulation of estrogen receptor mRNA in MCF-7 cells. Mol Endocrinol 3: 1782-1787, 1989.
35. Speir GR, Takeuchi K, Peitsch W and Johnson LR: Mucosal gastrin receptor VII. Up-and down-regulation. Am J Physiol 5: 243-249, 1982.
36. Kiss R, de Launoit Y, Danguy A, Paridaens R and Pasteels JL: Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of 'ovarian-independent' mouse mammary MXT tumors. Cancer Res 49: 2945-2951, 1989.
37. Fesus L, Davies PJA and Piacentini M: Apoptosis: Molecular mechanisms in programmed cell death. Eur J Cell Biol 56: 170-177, 1991.
38. Gerschenson LE and Rotello RJ: Apoptosis and cell proliferation are terms of the growth equation. In: Apoptosis: the Molecular Basis of Cell Death. Current Communications in Cell & Molecular Biology. Tomei LD and Cope FO (cds). Cold Spring Harbor Laboratory Press, pp175-192, 1991.
39. Kumar S, Huber J, Pena LA, Perez-Polo JR, Werrbach-Perez K and de Vellis J: Characterization of functional nerve growth factor-receptors in a CNS glial cell line: Monoclonal antibody 217c recognizes the nerve growth factor-receptor on C6 glioma cells. J Neurosci Res 27: 408-417, 1990.
40. Spoerri PE, Romanello S, Petrelli L, Negro A, Daltoso R, Leon A and Skapper SD: Nerve growth factor (NGF) receptors in a central nervous system glial cell line: upregulation by NGF and brain-derived neurotrophic factor. J Neurosci Res 33: 82-90, 1992.
41. Johnson CL and Johnson CG: Tumor necrosis factor and interleukin-1 down-regulate receptors for substance P in human astrocytoma cells. Brain Res 564: 79-85, 1991.
42. Adachi K, Belser P, Bender H, Li D, Rodeck U, Benveniste EN, Woo D, Schmiegel WH and Herlyn D: Enhancement of epidermal growth factor receptor expression in glioma cells by recombinant tumor necrosis factor α. Cancer Immunol Immunother 34: 370-376, 1992.